0001140361-17-036629.txt : 20170927 0001140361-17-036629.hdr.sgml : 20170927 20170927162727 ACCESSION NUMBER: 0001140361-17-036629 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170927 DATE AS OF CHANGE: 20170927 EFFECTIVENESS DATE: 20170927 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc. CENTRAL INDEX KEY: 0001600987 IRS NUMBER: 464137807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-295508 FILM NUMBER: 171104513 BUSINESS ADDRESS: STREET 1: 3525 DEL MAR HEIGHTS ROAD, #821 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (619) 987-7768 MAIL ADDRESS: STREET 1: 3525 DEL MAR HEIGHTS ROAD, #821 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: TOKALAS, INC. DATE OF NAME CHANGE: 20140225 D 1 primary_doc.xml X0708 D LIVE 0001600987 Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 858-434-1113 DELAWARE None TOKALAS, INC. Corporation true 2013 Scott L. Glenn c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Director Cam L. Garner c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Director David F. Hale c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Director Lauren G. Otsuki c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Executive Officer Chief Business Officer Langdon Miller c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Executive Officer Chief Medical Officer James B. Breitmeyer, M.D., Ph.D. c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Executive Officer Director President and Chief Executive Officer Brian Lannutti c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Executive Officer Chief Scientific Officer David Johnson c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Director Cam Gallagher c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Director Cooper Collins c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd, #821 San Diego CA CALIFORNIA 92130 Director Richard Vincent c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Executive Officer Chief Financial Officer Biotechnology Decline to Disclose 06b false 2017-09-12 true true true true true Series B-2 Preferred Stock false 0 11251125 6850397 4400728 false 121 0 0 0 false Oncternal Therapeutics, Inc. /s/ James B. Breitmeyer James B. Breitmeyer, M.D., Ph.D. President and Chief Executive Officer 2017-09-27